|Back to main|
AutoGenomics pulls $60 million IPO
By: Renaissance Capital
AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its IPO on Friday, according to an underwriter. The Vista, CA-based company was founded in 1999 and booked $17 million in sales for the 12 months ended 9/30/2012. Leerink Swann was set to be the sole bookrunner on the deal.